The story of Sildenafil presents a interesting case for stakeholders in the pharmaceutical sector. While initially a tremendous success, creating billions, the intellectual property lapse and the subsequent flood of https://adult444723.ltfblog.com/40183001/the-little-copyright-and-big-pharma-a-speculative-play